VDR and airway hyperresponsiveness: It reduces eosinophilic inflammation and airway hyperresponsiveness by binding to the vitamin D receptor (VDR) expressed on immune cells, which in turn stimulates the differentiation of regulatory T cells and inhibits pro-inflammatory Th2 and Th17 responses [7, 8].